dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
RxNorm concept 1305214, clinical drug (scd). Prescribable name: dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet.
- RxCUI
- 1305214
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1305214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
dextromethorphan hydrobromide 20 MG / GG 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet; dextromethorphan hydrobromide 20 MG / guaiFENesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Related concepts
- guaifenesin 400 MG (SCDC, consists of)
- phenylephrine hydrochloride 10 MG (SCDC, consists of)
- dextromethorphan hydrobromide 20 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
Linked data
NDCs
- 52083028960
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1305214 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1305214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1305214. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.